SFShi Feng

Shi Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shi Feng has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Hongying Zhou

    Department of Human Anatomy, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, China

    3 shared publications
  • Jinhang Gao

    Department of Gastroenterology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China

    3 shared publications
  • Shilei Wen

    Department of Human Anatomy, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China

    3 shared publications
  • Hong‑Ying Zhou

    Department of Human Anatomy, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China

    2 shared publications
  • Huan Tong

    Department of Human Anatomy, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China

    2 shared publications
  • Linhao Zhang

    Department of Gastroenterology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China

    2 shared publications

Latest Publications

  • Open Access

    Novel partial common bile duct ligation procedure in rats with reduced mortality and delayed onset of cirrhosis

    by Wanrong Xia, Hongji Yao, Tongxin Mu, Hui Liu, Jianhua Chen, Shi Feng, Shilei Wen

    Common bile duct ligation (BDL) in rats is a widely used animal model for the study of cholestatic liver injury; however, it has a high mortality rate and leads to rapid disease progression. To address these limitations, the present study developed a simplified partial BDL (p‑BDL) procedure by inserting a 26G disposable venous indwelling needle during ligation of the common bile duct, and subsequently removing the needle to create a narrow passage through the ligature points. The rats were euthanized 1 or 2 months after the procedure for histological, immunohistochemical and gelatin zymography analyses of the liver. Notably, no animals died during the experimental period, demonstrating the low mortality rate of the model. When assessed 1 month post‑p‑BDL, the rats exhibited mild liver fibrosis, while at 2 months, severe liver fibrosis was observed. Corresponding changes in liver function indices were also noted. Specifically, markers of liver fibrosis, including collagen I, collagen III and α‑smooth muscle actin, as well as matrix metalloproteinase (MMP)‑2 and MMP‑9, which contribute to extracellular matrix degradation, were significantly upregulated following p‑BDL. These findings are similar to those observed following BDL, and indicate that the p‑BDL model was successfully established. This model mitigates the drawbacks of traditional BDL and mimics chronic cholestatic cirrhosis, as observed clinically.


  • Open Access

    High expression of KIF3A is a potential new parameter for the diagnosis and prognosis of breast cancer

    by Peixuan Xia, Shihua Chu, Geng Liu, Guoqing Chen, Tao Yi, Shi Feng, Hongying Zhou

    Kinesin Family Member 3A (KIF3A) was recognized as a key factor of ciliogenesis and transport system of primary cilia in normal cells. However, its possible function on cancer cells has yet to be identified. In the present study, microarray tissue chips, including 230 breast cancer samples, were applied to determine the KIF3A expression pattern by immunological histological chemistry. Statistical analysis on the KIF3A expression level and the currently used clinicopathological characteristics of breast cancer patients was carried out. Follow‑up data of these patients over 10 years were also used to evaluate the relationship between KIF3A and the survival rate. The expression levels of KIF3A were significantly higher in 140 breast cancer tissues than those of 90 para‑carcinoma samples, which served as controls (P<0.001). In addition, in a further 70 paired samples, the same higher expression level was observed in cancer tissues compared with their self‑paired controls (P<0.001). Furthermore, the high expression of KIF3A in breast cancer tissue correlated with the status of estrogen receptor, androgen receptor, epidermal growth factor receptor and Ki‑67 of breast cancer patients, and were also related to their pathology grade and lymph node metastasis. The survival analysis showed a better survival rate in the patients with a higher expression level of KIF3A. Collectively, the triadic associations of KIF3A, the currently used clinicopathological parameters and survival rate suggest that KIF3A is involved in the tumorigenesis and progression of breast cancer. Thus, KIF3A could be considered a promising novel prognostic index in breast cancer.


  • Modification of the method to establish a hepatic VX2 carcinoma model in rabbits

    by Huan Tong, Li‑Geng Duan, Hong‑Ying Zhou, Shi Feng

    The hepatic VX2 carcinoma model in rabbits is widely used for the preclinical study of hepatocellular carcinoma. In the present study, a modification was made to the conventional method to establish the animal model, as the conventional method gives rise to frequent tumor seeding due to the drop‑out of tumor fragments. In order to evaluate each distinct method of establishing the model, the rabbits were divided into two groups: Group A (the conventional method; n=20) and group B (the modified method; n=20). All surgical details were recorded for reference. At 14 days post‑surgery, contrast‑enhanced computed tomography (CECT) and autopsy were conducted. Microscopic morphology of tumor cells was observed using hematoxylin and eosin (H&E) and transmission electron microscopy (TEM). Vascular endothelial growth factor (VEGF) and cluster of differentiation (CD)31 were detected via immunochemistry and reverse transcription-polymerase chain reaction. In total, 19 rabbits in each group succeeded in model establishment. Throughout the surgery, group A experienced a longer surgery time compared with group B (group A vs. group B, 22.57±1.34 vs. 20.17±1.50 min; P<0.001), an increased tumor fragment drop‑out frequency (group A vs. group B, 1.84±0.96 vs. 1.16±0.38; P=0.008) and an increased peritoneal nodule incidence (group A vs. group B, 35 vs. 5%, P=0.042). As for CECT, H&E and TEM, hepatic VX2 allografts in the two groups demonstrated similar imaging presentations and tumor cell morphology. In addition, VEGF and CD31 levels did not differ between the two groups. In conclusion, the modified method for the establishment of hepatic VX2 carcinoma model in rabbits may decrease tumor fragment drop‑out frequency during surgery and incidence of tumor seeding without affecting the properties of VX2 carcinoma.


  • Morphological and molecular variations induce mitochondrial dysfunction as a possible underlying mechanism of athletic amenorrhea

    by Ruo‑Hong Xiong, Shi‑Lei Wen, Qiang Wang, Hong‑Ying Zhou, Shi Feng

    Female athletes may experience difficulties in achieving pregnancy due to athletic amenorrhea (AA); however, the underlying mechanisms of AA remain unknown. The present study focuses on the mitochondrial alteration and its function in detecting the possible mechanism of AA. An AA rat model was established by excessive swimming. Hematoxylin and eosin staining, and transmission electron microscopic methods were performed to evaluate the morphological changes of the ovary, immunohistochemical examinations and radioimmunoassays were used to detect the reproductive hormones and corresponding receptors. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was used to test the mtDNA copy number. PCR and western blot analysis were used to test the expression of ND2. The change of morphological features of the rat ovaries revealed evident abnormalities. Particularly, the features of the mitochondria were markedly altered. In addition, reproductive hormones in the serum and tissues of AA rats were also detected to evaluate the function of the ovaries, and the levels of these hormones were significantly decreased. Furthermore, the mitochondrial DNA copy number (mtDNA) and expression of NADH dehydrogenase subunit 2 (ND2) were quantitated by qPCR or western blot analysis. Accordingly, the mtDNA copy number and expression of ND2 expression were markedly reduced in the AA rats. In conclusion, mitochondrial dysfunction in AA may affect the cellular energy supply and, therefore, result in dysfunction of the ovary. Thus, mitochondrial dysfunction may be considered as a possible underlying mechanism for the occurrence of AA.


  • Open Access

    Methylation of mitochondrial DNA displacement loop region regulates mitochondrial copy number in colorectal cancer

    by Huan Tong, Linhao Zhang, Jinhang Gao, Shilei Wen, Hongying Zhou, Shi Feng

    It is not established whether de‑methylation of the displacement loop (D‑loop) region if mitochondrial DNA (mtDNA) directly influences mtDNA copy number and further alters the cell cycle, apoptosis and cell proliferation in colorectal cancer. The current study employed cell viability assays, cell cycle analysis, and mtDNA methylation analysis using 5 colorectal cancer cell lines. The present results demonstrated that 5‑aza‑2'‑deoxycytidine (5‑AZA), a DNA hypomethylating agent, significantly increased proliferation of Lovo and Colo‑205 colorectal cancer cell lines. In Colo‑205 cells, the proportion of G0/G1 phase cells was increased following 5‑AZA treatment. Additionally, the apoptosis rate in Colo‑205 cells was decreased by 5‑AZA treatment. Compared with their controls, a significantly higher mtDNA copy number was observed in Colo‑205 and Lovo cells following 5‑AZA treatment. Notably, the Colo‑205 and Lovo cells had relatively higher methylation levels at the 4 and 6th/7th CpG sites of D‑loop region, respectively, compared with the levels at the corresponding sites following 5‑AZA treatment. However, in HCT116, SW480, LS‑174T, and HT‑29 cells, 5‑AZA treatment did not induce a significant change in proliferation, cell cycle, apoptosis and mtDNA copy number. Demethylation at the 4 and 6th/7th CpG sites of the D‑loop region of HCT116, SW480, LS‑174T and HT‑29 cells was not observed following 5‑AZA treatment. In conclusion, de‑methylation of specific sites on CpG islands of D‑loop promoter may lead to the elevation of mtDNA copy number in colorectal cancer, triggering alterations in biological behaviors, including increased cell proliferation, reduced apoptosis and a relative cell cycle arrest in G0/G1 phase.


  • Open Access

    p53 increase mitochondrial copy number via up-regulation of mitochondrial transcription factor A in colorectal cancer

    by Shilei Wen, Jinhang Gao, Linhao Zhang, Hongying Zhou, Dingzhi Fang, Shi Feng

    P53 increase mitochondrial copy number via up-regulation of mitochondrial transcription factor A in colorectal cancer


  • De-methylation of displacement loop of mitochondrial DNA is associated with increased mitochondrial copy number and nicotinamide adenine dinucleotide subunit 2 expression in colorectal cancer

    by Jinhang Gao, Shilei Wen, Hongying Zhou, Shi Feng

    DNA methylation occurs in the displacement loop (D-loop) region of mammals; however, D-loop regions of certain tumor tissue types were found to be de‑methylated. Whether hypomethylation of the D‑loop region is involved in the regulation of the mitochondrial DNA (mtDNA) copy number and nicotinamide adenine dinucleotide subunit 2 (ND‑2) expressions in colorectal cancer has remained elusive. In the present study, the association between methylation status of the D‑loop region, mtDNA copy number and ND‑2 expression was investigated in 65 colorectal cancer specimens and their corresponding non‑cancerous tissues. In addition, a de‑methylation experiment was performed on the Caco‑2 colorectal cancer cell line by using 5‑aza-2'-deoxycytidine (5‑Aza). The methylation rate of the D‑loop region in all 65 colorectal cancer tissues was markedly reduced when compared with that of their corresponding non‑cancerous tissues (13.8 vs. 81.5%; P<0.05). Furthermore, the methylation rate of the D‑loop region in colorectal cancer tissues was markedly decreased in clinicopathological stages III and IV compared with that in clinicopathological stages I and II (7.1 and 0% vs. 25 and 16%; P<0.05). In addition, the mean relative mtDNA copy number and ND‑2 expression in colorectal cancer tissues were increased compared with those in the corresponding non‑cancerous tissues. De‑methylation of the D‑loop region was associated with an elevated mtDNA copy number and an increased ND‑2 expression. Furthermore, the mtDNA copy number and ND‑2 expression in Caco‑2 cells were significantly increased after 5‑Aza treatment. In conclusion, de‑methylation of the D‑loop region is likely to be involved in the regulation of the mtDNA copy number and ND-2 expression.